A jury awarded $40 million to two women who say Johnson & Johnson’s talcum powder caused their ovarian cancer, citing the company’s failure to warn of risks.

A Los Angeles jury awarded $40 million to two women who claimed Johnson & Johnson’s talcum powder caused their ovarian cancer, finding the company failed to warn consumers despite knowing of potential risks for decades. The verdict, part of over 67,000 similar lawsuits, adds to a series of legal setbacks for the company, which stopped selling talc-based products in the U.S. in 2020 and switched to cornstarch. Johnson & Johnson plans to appeal, maintaining its products are safe and asbestos-free, and has had multiple bankruptcy plans to settle claims rejected.